Physician profile
Farris Sandhu
NPI 1740357581
$1,872.74
in general payments reported to CMS, 2019-2025
16 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.00 · 2020: $126 · 2021: $335 · 2022: $234 · 2023: $429 · 2024: $334 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $223.80 | 2022-2023 | Nucala |
| Genzyme Corporation | $182.14 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $175.58 | 2023-2024 | Imfinzi, Lynparza |
| Portola Pharmaceuticals, LLC | $126.35 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $124.99 | 2022 | |
| Horizon Therapeutics Plc | $124.48 | 2023 | Krystexxa |
| Novartis Pharmaceuticals Corporation | $121.22 | 2024 | |
| Si-Bone, INC. | $121.13 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $120.68 | 2023 | Austedo Xr |
| Neurelis, INC. | $117.93 | 2025 | Valtoco |
| Biohaven Pharmaceuticals, INC. | $117.86 | 2021 | |
| Aurinia Pharma U.S., INC. | $105.60 | 2024 | Lupkynis |
| Regeneron Healthcare Solutions, INC. | $95.65 | 2021 | |
| Coloplast Corp | $47.00 | 2019 | |
| Exact Sciences Corporation | $43.43 | 2025 | Cologuard Collection Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.90 | 2025 | Aveir |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farris Sandhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.